These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36396043)

  • 1. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
    Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
    J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity.
    Wang H; Zhong M; Li Y; Li K; Wu S; Guo T; Cen S; Jiang J; Li Z; Li Y
    Antiviral Res; 2019 May; 165():23-33. PubMed ID: 30862444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.
    Nguyen DH; Hu J
    J Virol; 2008 Jul; 82(14):6852-61. PubMed ID: 18480459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
    Baumert TF; Rösler C; Malim MH; von Weizsäcker F
    Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
    Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
    Nguyen DH; Gummuluru S; Hu J
    J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
    Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
    Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Bioactivity of
    Cui AL; Sun WF; Zhong ZJ; Jin J; Xue ST; Wu S; Li YH; Li ZR
    Drug Des Devel Ther; 2020; 14():3723-3729. PubMed ID: 32982177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC-mediated interference with hepadnavirus production.
    Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
    Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
    Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
    J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems.
    Zhao D; Wang X; Lou G; Peng G; Li J; Zhu H; Chen F; Li S; Liu D; Chen Z; Yang Z
    Virus Res; 2010 Aug; 151(2):213-9. PubMed ID: 20510315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
    Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
    PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
    J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.
    Yang L; Shi LP; Chen HJ; Tong XK; Wang GF; Zhang YM; Wang WL; Feng CL; He PL; Zhu FH; Hao YH; Wang BJ; Yang DL; Tang W; Nan FJ; Zuo JP
    Acta Pharmacol Sin; 2014 Mar; 35(3):410-8. PubMed ID: 24487969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC.
    Ren F; Li W; Zhao S; Wang L; Wang Q; Li M; Xiang A; Guo Y
    J Med Virol; 2021 Jun; 93(6):3672-3678. PubMed ID: 32779759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
    Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.